Praise for Proteomics

The method of the year for 2012 is targeted proteomics, says Methagora, Nature Methods' blog. "Targeted proteomics … offers a tantalizing opportunity to bring a sampling of the power of mass spectrometry to the wider community of biologists," writes Daniel Evanko there. "The assays are simpler, easier to run and well suited to the hypothesis-driven experiments that are the mainstay of biological research."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.